Left Ventricular Hypertrophy:グローバル臨床試験レビューH2, 2013...市場調査レポートについてご紹介

【英文タイトル】Left Ventricular Hypertrophy Global Clinical Trials Review, H2, 2013

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Left Ventricular Hypertrophy 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by G7 Nations 16
Clinical Trials in G7 Nations by Trial Status 17
Clinical Trials by E7 Nations 18
Clinical Trials in E7 Nations by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Unaccomplished Trials of Left Ventricular Hypertrophy 23
Subjects Recruited Over a Period of Time 24
Prominent Sponsors 25
Top Companies Participating in Left Ventricular Hypertrophy Therapeutics Clinical Trials 26
Prominent Drug Comparison 28
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
Novartis AG 29
Clinical Trial Overview of Novartis AG 29
Abbott Laboratories 30
Clinical Trial Overview of Abbott Laboratories 30
Sanofi 31
Clinical Trial Overview of Sanofi 31
Johnson & Johnson 32
Clinical Trial Overview of Johnson & Johnson 32
AstraZeneca PLC 33
Clinical Trial Overview of AstraZeneca PLC 33
Merck & Co., Inc. 34
Clinical Trial Overview of Merck & Co., Inc. 34
Mayo Clinic 35
Clinical Trial Overview of Mayo Clinic 35
GlaxoSmithKline plc 36
Clinical Trial Overview of GlaxoSmithKline plc 36
AbbVie Inc. 37
Clinical Trial Overview of AbbVie Inc. 37
Clinical Trial Overview of Top Institutes / Government 38
National Heart, Lung, and Blood Institute 38
Clinical Trial Overview of National Heart, Lung, and Blood Institute 38
University of Dundee 39
Clinical Trial Overview of University of Dundee 39
Washington University School of Medicine 40
Clinical Trial Overview of Washington University School of Medicine 40
Medical University of Vienna 41
Clinical Trial Overview of Medical University of Vienna 41
Aarhus University 42
Clinical Trial Overview of Aarhus University 42
Wayne State University 43
Clinical Trial Overview of Wayne State University 43
Azienda Ospedaliera Universitaria San Martino 44
Clinical Trial Overview of Azienda Ospedaliera Universitaria San Martino 44
Wuhan General Hospital of Guangzhou Military Command 45
Clinical Trial Overview of Wuhan General Hospital of Guangzhou Military Command 45
Mustafa Kemal Universitesi 46
Clinical Trial Overview of Mustafa Kemal Universitesi 46
Kyoto University 47
Clinical Trial Overview of Kyoto University 47
Five Key Clinical Profiles 48
Appendix 103
Abbreviations 103
Definitions 103
Research Methodology 104
Secondary Research 104
About GlobalData 105
Contact Us 105
Disclaimer 105
Source 106


【レポート販売概要】

■ タイトル:Left Ventricular Hypertrophy:グローバル臨床試験レビューH2, 2013
■ 英文:Left Ventricular Hypertrophy Global Clinical Trials Review, H2, 2013
■ 発行日:2013年11月15日
■ 調査会社:GlobalData
■ 商品コード:GDATA403162706
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。